Latest 30 News in the Life Sciences Industry
PR Newswire Association LLC.
Chonnam National University Study Explores Therapeutic Potential of Human Dental Pulp Stem Cell Secretome in Post-Stroke Functional Recovery
06 Oct 2026
PR Newswire Association LLC.
Chungnam National University Researchers Develop Model for Predicting Growth Hormone Therapy Responses in Children With Short Stature
05 Oct 2026
PR Newswire Association LLC.
Yuyu Teijin Medicare Uses Drones to Deliver Medical Supplies to Patients on Korea's Remote Islands
29 Sep 2026
PR Newswire Association LLC.
Daewoong Pharmaceutical Presents Baseline Characteristics of 104 Patients in Global Phase 2 Trial for IPF Drug Candidate 'Bersiporocin' at ERS 2026
24 Sep 2026
PR Newswire Association LLC.
PharmaResearch Officially Launches REJURAN in Hungary, Expanding Its Presence in Europe
22 Sep 2026
PR Newswire Association LLC.
PharmaResearch Launches REJURAN in Saudi Arabia, Expanding Presence Across the Middle East
18 Sep 2026
PR Newswire Association LLC.
Korea University Study Reveals How a Blood Biomarker Tracks Response to Lecanemab in Early Alzheimer's Disease
14 Sep 2026
PR Newswire Association LLC.
Korea University Study Uncovers How mRNA Vaccination May Broaden Flu Antibody Responses
11 Sep 2026
PR Newswire Association LLC.
Korean Biotech Company K-Medichem Expands Global Market Reach with PDRN Derma Skincare Line in Vietnam, Indonesia and Beyond
08 Sep 2026
PR Newswire Association LLC.
BS PHARM KOREA Strengthens INHILO+ Market Development Through Distribution and Clinical Collaboration
06 Sep 2026
PR Newswire Association LLC.
Orbis Flying Eye Hospital Marks 20 Years of Partnership with Macau
04 Sep 2026
PR Newswire Association LLC.
Alcon's Clareon Monofocal IOL Receives EUMDR Certification Through TÜV SÜD
01 Sep 2026
PR Newswire Association LLC.
Subsidised Access to Columvi® Now Available for Eligible Patients with Relapsed or Refractory DLBCL in Singapore
31 Aug 2026
PR Newswire Association LLC.
Samsung Biologics Announces KRW 3 Trillion Rights Offering to Fund Its Next-Phase Expansion
28 Aug 2026
PR Newswire Association LLC.
SU Group Wins US$2.4 Million Follow-on Award, Expanding Landmark Smart-Hospital Project to US$13.7 Million
26 Aug 2026
GlobeNewswire
FDA approves Pluvicto for PSMA+ metastatic hormone-sensitive prostate cancer (mHSPC), advancing potential new standard of care across metastatic disease
31 Jul 2026
GlobeNewswire
Novartis delivered sales growth in Q2 and further advanced the pipeline; Full-year guidance reaffirmed
21 Jul 2026
GlobeNewswire
Novartis Fabhalta® (iptacopan) receives FDA traditional approval as first and only complement inhibitor to significantly slow kidney function decline in primary IgAN
17 Jul 2026
GlobeNewswire
SPRINT® PNS Publication Highlights Sustained Benefits in Low Back Pain Patients
07 Jul 2026
GlobeNewswire
Novartis agrees to acquire Myricx Bio, advancing next-generation antibody-drug conjugate innovation with a novel NMTi payload, expanding options for cancer patients
06 Jul 2026
GlobeNewswire
NovMetaPharma and the FSHD Canada Foundation Establish Collaboration to Advance Cyclo-Z, a First-in-Class Oral Muscle-Preserving Therapy, into Facioscapulohumeral Muscular Dystrophy
06 Jul 2026
GlobeNewswire
Novartis receives European Commission approval for Itvisma® for spinal muscular atrophy (SMA)
02 Jul 2026
GlobeNewswire
FDA Selects Kyowa Kirin for PreCheck Pilot Program to Accelerate Manufacturing Timelines and Enhance Supply Chain Resilience
30 Jun 2026
GlobeNewswire
New Analyses Advance Understanding of Long-Term Survival Outcomes with Mogamulizumab in Mycosis Fungoides and Sézary Syndrome
30 Jun 2026
Latest News All News
Upcoming Events All Events
- October 2026
- Yokohama: BioJapan
- Queensland: AusBiotech Invest
- Queensland: AusBiotech International Conference